Log in to save to my catalogue

miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin

miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1765947364

miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin

About this item

Full title

miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2016-01, Vol.35 (3), p.323-332

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Epithelial–mesenchymal transition (EMT) has an established role in promoting tumor progression and the acquisition of therapeutic resistance. Here, the EMT phenotype was detected in cisplatin-resistant ovarian cancer tissues and cell lines, and correlated with decreased miR-186 expression, increased Twist1 expression, chemoresistance and poor progn...

Alternative Titles

Full title

miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1765947364

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1765947364

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/onc.2015.84

How to access this item